Starten Sie Ihre Suche...


Durch die Nutzung unserer Webseite erklären Sie sich damit einverstanden, dass wir Cookies verwenden. Weitere Informationen

Univ.-Prof. Dr. med. Christoph Huber

FB 04 - Universitätsmedizin, Johannes Gutenberg-Universität Mainz

Langenbeckstr. 4, Raum: 302

  • 06131/17-72 81
  • 06131/17-66 78
Publikationen
Ergebnisse pro Seite:  10

Kindler, T.; Breitenbuecher, F.; Kasper, S. et al.

In BCR-ABL-positive cells, STAT-5 tyrosine-phosphorylation integrates signals induced by imatinib mesylate and Ara-C

Leukemia. the journal of normal and malignant hemopoiese ; official journal of the Leukemia Research Fund U.K. Bd. 17. H. 6. Basingstoke: Nature Publ. Group 2003 S. 999 - 1009


Schuler, M.; Maurer, U.; Goldstein, J.C. et al.

p53 triggers apoptosis in oncogene-expressing fibroblasts by the induction of Noxa and mitochondrial Bax translocation

London: Arnold 2003 S. 451 - 460


Huber, Christoph; Chipuk, J. E.; Maurer, U. et al.

Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription

Cancer Cell. Bd. Cancer Cell. 2003 S. 371-381


Milosevic, Javorina; Hoffarth, Sandra; Huber, Claudia et al.

The DNA damage-induced decrease of Bcl-2 is secondary to the activation of apoptotic effector caspases

Oncogene. an international journal. Bd. 22. H. 44. Basingstoke: Nature Publ. Group 2003 S. 6852 - 6856


Huber, Christoph; Guilhot, F.; Larson, R. et al.

The IRIS Study: International Randomized study of Interferon and low-dose Ara-C versus STI571 (imatinib) in patients with newly-diagnosed chronic phase chronic myeloid leukemia

New England Journal of Medicine. Bd. New England Journal of Medicine. 2003 S. 994-1004


Huber, Christoph; Kantarjian, C. L.; Sawyers, A. et al.

Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia

New England Journal of Medicine. Bd. New England Journal of Medicine. 2002 S. 645-652


Hartwig, U.F.; Robbers, M.; Wickenhauser, C. et al.

TRANSPLANTATION - Murine acute graft-versus-host disease can be prevented by depletion of alloreactive T lymphocytes using activation-induced cell death

Blood. the journal of hematology. Bd. 99. H. 8. Washington, DC: American Society of Hematology 2002 S. 3041 - 3049


Britten, Cedrik M.; Meyer, Ralf G.; Kreer, Tanja et al.

The use of HLA-A*0201-transfected K562 as standard antigen-presenting cells for CD8+ T lymphocytes in IFN-g ELISPOT assays

Amsterdam [u.a.]: Elsevier 2001 S. 95 - 110


Seliger, Barbara; Hohne, Alexandra; Knuth, Alexander et al.

Analysis of the Major Histocompatibility Complex Class I Antigen Presentation Machinery in Normal and Malignant Renal Cells: Evidence for Deficiencies Associated with Transformation and Progression

Cancer research. an official organ of the American Association for Cancer Research. Bd. 56. H. 8. Birmingham, Ala. [u.a.]: AACR 1996 S. 1756 - 1760


Albrecht, T.; Schwab, R.; Peschel, C. et al.

Cationic lipide mediated transfer of c-abl and bcr antisense oligonucleotides to immature normal myeloid cells: Uptake, biological effects and modulation of gene expression

Annals of hematology. organ of Deutsche Gesellschaft für Hämatologie und Onkologie, Gesellschaft für Thrombose- und Hämostaseforschung, Österreichische Gesellschaft für Hämatologie und Onkologie. Bd. 72. H. 2. Berlin: Springer 1996 S. 73 - 80